Overview
CV market data
Price History
CV price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.03 Diluted earnings per share over the trailing twelve months.
- Beta
- -1.63 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -198.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.43 – $15.37 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $333.8M · P/B 37.76 · P/S 24.61.
Company News
CapsoVision Q2 2026 Earnings Call TranscriptBenzinga · Aug 13, 2026, 9:16 PM
CapsoVision Files Prospectus For Up To $250M Offering Of Common Stock, Preferred Stock, Warrants, Rights And UnitsBenzinga · Aug 13, 2026, 9:15 PM
CapsoVision Enters Sales Agreement With Cantor FitzGerald For ATM Offering Up To $100MBenzinga · Aug 13, 2026, 9:10 PM
CapsoVision Q2 EPS $(0.15) Misses $(0.13) Estimate, Sales $3.643M Miss $3.813M EstimateBenzinga · Aug 13, 2026, 8:07 PM
8-K filing — CapsoVision, Inc (CV)SEC EDGAR · Aug 13, 2026, 8:07 PM
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga · May 18, 2026, 12:05 PM
Transcript: CapsoVision Q1 2026 Earnings Conference CallBenzinga · May 14, 2026, 9:18 PM
CapsoVision Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $2.792M Miss $3.188M EstimateBenzinga · May 14, 2026, 8:08 PM